St Louis Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Sell
1,703
-511
-23% -$518K 0.18% 66
2025
Q4
$2.38M Buy
2,214
+1,441
+186% +$1.38M 0.27% 48
2025
Q3
$590K Hold
773
0.07% 85
2025
Q2
$603K Hold
773
0.08% 84
2025
Q1
$638K Buy
773
+187
+32% +$156K 0.09% 80
2024
Q4
$452K Sell
586
-101
-15% -$83.6K 0.06% 91
2024
Q3
$609K Sell
687
-305
-31% -$274K 0.09% 86
2024
Q2
$898K Hold
992
0.14% 72
2024
Q1
$772K Buy
992
+305
+44% +$217K 0.12% 79
2023
Q4
$400K Hold
687
0.07% 92
2023
Q3
$369K Hold
687
0.07% 88
2023
Q2
$322K Hold
687
0.06% 90
2023
Q1
$236K Hold
687
0.05% 99
2022
Q4
$251K Buy
+687
New +$244K 0.05% 94
2022
Q3
Sell
-687
Closed -$223K 96
2022
Q2
$223K Buy
+687
New +$206K 0.05% 94
2018
Q3
Sell
-8,749
Closed -$747K 85
2018
Q2
$747K Buy
+8,749
New +$719K 0.25% 53

Other funds holding LLY

St Louis Trust's LLY Position: Q1 2026 in Review

St Louis Trust reduced its Eli Lilly (LLY) stake by 23% in Q1 2026, selling an estimated $518K and leaving 1,703 shares worth $1.57M. The position accounts for 0.18% of the portfolio, ranked #66.

St Louis Trust first reported a position in LLY in Q2 2018 and has held it in 16 quarters since. The position peaked at $2.38M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • St Louis Trust held 1,703 shares of Eli Lilly worth $1.57M as of Q1 2026.
  • St Louis Trust sold 511 Eli Lilly shares in Q1 2026, an estimated $518K.
  • Eli Lilly made up 0.18% of St Louis Trust's portfolio in Q1 2026, its #66 holding.
  • St Louis Trust first reported a position in Eli Lilly in Q2 2018 and has held it in 16 quarters since.
  • St Louis Trust's Eli Lilly position peaked at $2.38M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on St Louis Trust's 13F filing for Q1 2026, filed 14 May 2026.